Annual report pursuant to Section 13 and 15(d)

CollabRx Acquisition (Tables)

v2.4.0.6
CollabRx Acquisition (Tables)
12 Months Ended
Mar. 31, 2013
CollabRx Acquisition [Abstract]  
Purchase Price Allocation for Acquisition of CollabRx
The purchase price for the CollabRx acquisition was allocated as follows:

PURCHASE PRICE ALLOCATION FOR ACQUISITION OF COLLABRX
 
Assets acquired:
 
 
 
Developed Technology
 
$
720
 
Customer Relationships
 
 
433
 
Trade Name
 
 
346
 
Non Compete Agreement
 
 
151
 
Cash
 
 
476
 
AP and accrueds
 
 
-333
 
Deferred tax liability
 
 
-664
 
Goodwill
 
 
603
 
Total Acquired Assets, net
 
 
1,732
 
 
Purchase Price summary:
 
$
932
 
Common Stock Consideration
 
 
500
 
Promissory Note Assumed
 
 
300
 
Loan Note Payable Assumed
 
 
1,732